Retraction notice to “Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer” [International Journal of Biological Macromolecules 245 (2023) 125510] (International Journal of Biological Macromolecules (2023) 245, (S0141813023024042), (10.1016/j.ijbiomac.2023.125510))

Suggested Citation

Kianpour M., Huang C.W., Vejvisithsakul P.P., Wang J.Y., Chien-Feng L., Shiao M.S., Pan C.T., Shiue Y.L. Retraction notice to “Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer” [International Journal of Biological Macromolecules 245 (2023) 125510] (International Journal of Biological Macromolecules (2023) 245, (S0141813023024042), (10.1016/j.ijbiomac.2023.125510)). International Journal of Biological Macromolecules Vol.293 (2025). doi:10.1016/j.ijbiomac.2024.138914 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/102868

Availability

Collections